Several salivary proteins have been investigated as potential biomarkers in human cancers, including oral cancer; among them is the mitochondrial translocator protein (18 kDa), or TSPO—previously known as the peripheral benzodiazepine receptor (PBR) [10–12]. Here, TSPO is linked to lip and oral cavity carcinoma.